HPR59 Do All US Payer Archetypes Consider the Same Sources of Evidence to Inform Their Drug Policies?

Abstract

Authors

Conceicao R Da P Okorozo P Narvekar

Full Text Cite This Article
Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×